Quality management // № 12, December 2025

Market leaders have long viewed post-marketing surveillance not as a costly obligation, but as an investment in their own future. There are examples in the history of medical technology when critical flaws were later discovered in the latest developments that received certification. Mass product recalls, lawsuits, destroyed consumer trust – all this cost companies much more than the development of a timely and transparent monitoring system.

The text of the article is available only in Ukrainian